FAKTOR-OPTIONSSCHEIN - GSK PLC Share Price

Certificat

DE000MG0LWE0

Real-time Bid/Ask 04:18:45 01/07/2024 pm IST
10.95 EUR / 11.01 EUR +2.43% Intraday chart for FAKTOR-OPTIONSSCHEIN - GSK PLC
Current month+118.33%
1 month+120.58%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart GSK PLC
Chart FAKTOR-OPTIONSSCHEIN - GSK PLC
Date Price Change
01/24/01 10.92 +1.87%
28/24/28 10.72 -4.88%
27/24/27 11.27 +38.96%
26/24/26 8.11 -0.25%
25/24/25 8.13 +5.31%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 02:28 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying GSK PLC
Issuer Morgan Stanley
WKN MG0LWE
ISINDE000MG0LWE0
Date issued 21/03/2024
Strike 1,721 p
Maturity Unlimited
Parity 0.21 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 14.42
Lowest since issue 4.06
Spread 0.06
Spread %0.55%

Company Profile

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.
Sector
-
More about the company

Ratings for GSK plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: GSK plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
15.3 GBP
Average target price
20.28 GBP
Spread / Average Target
+32.62%
Consensus